IOL Chemicals & Pharmaceuticals surged 7.76% to Rs 441.05 after China's National Medical Products Administration (NMPA) approved the company's Fenofibrate drug.
The NMPA's green light paves the way for IOL Chemicals to export its Fenofibrate to the Chinese market. The drug is used to treat high cholesterol and triglyceride levels in the blood.IOL Chemicals and Pharmaceuticals is a pharma API and speciality chemicals manufacturer. Its consolidated net profit declined 57.36% to Rs 27.62 crore on 14.18% fall in net sales to Rs 503.92 crore in Q4 March 2024 over Q4 March 2023.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app